DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)

MANUFACTURER: Glentek

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Therapeutic Goods Administration (TGA)

Medicines & Healthcare products Regulatory Agency (MHRA)

The Medicines Evaluation Board (MEB)

Glentek (riluzole) is a medication manufactured by Concordia Pharmaceuticals Inc. for treating ALS by reducing the release of glutamate that causes muscle weakness.